4Henter JI, Home A, Arico M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer,2007,48 (2) : 124-31.
5Bennett TD, Fluchel M, Hersh AO, et al. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum, 2012,64(12) :4135-4142.
6Atteritano M, David A, Bagnato G, et al. Haemophagocytic syn- drome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci ,2012,16(10) : 1414-1424.
7Bode SF, Lehmberg K, Maul-Pavicic A, et al. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistio- cytosis. Arthritis Res Ther, 2012,14 ( 3 ) : 213 -225.
8Castillo L,Carcillo J. Secondary hemophagocytic lymphohistio- cytosis and severe sepsis/systemic inflammatory response syn- drome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med ,2009,10 ( 3 ) :387-392.
9Demirkol D, Yilthzdas D, Bayrakci B, et al. Hyperferritinemia in the critically ill child with secondary hemophagocytic lympho- histiocytosis/sepsis/multiple organ dysfunction syndrome/mac- rophage activation syndrome : what is the treatment?. Crit Care, 2012,16(2) : R52-63.
10Chiche L, Forel JM, Thomas G, et al. The role of natural killer cells in sepsis. J Biomed Biotechnol,2011,2011:986491.
